{"id":"https://openalex.org/W4362534720","doi":"https://doi.org/10.1158/1535-7163.22505436","title":"Supplementary Figures S1-S7 from Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody\u2013Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer","display_name":"Supplementary Figures S1-S7 from Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody\u2013Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362534720","doi":"https://doi.org/10.1158/1535-7163.22505436"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22505436","doi":"https://doi.org/10.1158/1535-7163.22505436","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22505436","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22505436","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058484248","display_name":"Song Cho","orcid":"https://orcid.org/0009-0007-6119-5269","observed_orcids":["https://orcid.org/0009-0007-6119-5269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Song Cho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039617409","display_name":"Francesca Zammarchi","orcid":"https://orcid.org/0000-0001-9457-2170","observed_orcids":["https://orcid.org/0000-0001-9457-2170"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Zammarchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"David G. Williams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David G. Williams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111968453","display_name":"Carin E.G. Havenith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carin E.G. Havenith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078346499","display_name":"Noel R. Monks","orcid":"https://orcid.org/0000-0001-6587-9827","observed_orcids":["https://orcid.org/0000-0001-6587-9827"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noel R. Monks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041426609","display_name":"Peter J Tyrer","orcid":"https://orcid.org/0000-0002-0358-1459","observed_orcids":["https://orcid.org/0000-0002-0358-1459"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Tyrer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014171089","display_name":"Fran\u00e7ois D\u2019Hooge","orcid":"https://orcid.org/0000-0003-2531-085X","observed_orcids":["https://orcid.org/0000-0003-2531-085X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francois D'Hooge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078061615","display_name":"Ryan L. Fleming","orcid":"https://orcid.org/0000-0002-0897-3742","observed_orcids":["https://orcid.org/0000-0002-0897-3742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan Fleming","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034994004","display_name":"Kapil Vashisht","orcid":"https://orcid.org/0000-0003-0550-0162","observed_orcids":["https://orcid.org/0000-0003-0550-0162"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kapil Vashisht","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076501775","display_name":"Nazzareno Dimasi","orcid":"https://orcid.org/0000-0001-9379-1646","observed_orcids":["https://orcid.org/0000-0001-9379-1646"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nazzareno Dimasi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068436456","display_name":"Fran\u00e7ois Bertelli","orcid":"https://orcid.org/0009-0006-3448-2089","observed_orcids":["https://orcid.org/0009-0006-3448-2089"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francois Bertelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034251438","display_name":"Simon Corbett","orcid":"https://orcid.org/0009-0001-6166-1609","observed_orcids":["https://orcid.org/0009-0001-6166-1609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Corbett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013463645","display_name":"Lauren R. Adams","orcid":"https://orcid.org/0000-0002-0906-468X","observed_orcids":["https://orcid.org/0000-0002-0906-468X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren Adams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010483928","display_name":"Halla W. Reinert","orcid":"https://orcid.org/0000-0002-8139-3568","observed_orcids":["https://orcid.org/0000-0002-8139-3568"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Halla W. Reinert","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8139-3568","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008181030","display_name":"Sandamali Dissanayake","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandamali Dissanayake","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054078946","display_name":"Charles E. Britten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles E. Britten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032183094","display_name":"Wanda King","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wanda King","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029127660","display_name":"Karma Dacosta","orcid":"https://orcid.org/0000-0002-9600-1889","observed_orcids":["https://orcid.org/0000-0002-9600-1889"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karma Dacosta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045583717","display_name":"Ravinder Tammali","orcid":"https://orcid.org/0000-0002-4318-2516","observed_orcids":["https://orcid.org/0000-0002-4318-2516"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravinder Tammali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009094651","display_name":"Kevin P. Schifferli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Schifferli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079613331","display_name":"Patrick Strout","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Strout","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081981073","display_name":"Martin Korade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Korade","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083508937","display_name":"Mary Jane Hinrichs","orcid":"https://orcid.org/0000-0002-3816-2334","observed_orcids":["https://orcid.org/0000-0002-3816-2334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Jane Masson Hinrichs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017223848","display_name":"Simon Chivers","orcid":"https://orcid.org/0009-0002-3916-3221","observed_orcids":["https://orcid.org/0009-0002-3916-3221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Chivers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018745405","display_name":"Eva Corey","orcid":"https://orcid.org/0000-0002-9244-3807","observed_orcids":["https://orcid.org/0000-0002-9244-3807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva Corey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9244-3807","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100317863","display_name":"He Liu","orcid":"https://orcid.org/0000-0002-4103-312X","observed_orcids":["https://orcid.org/0000-0002-4103-312X","https://orcid.org/0009-0000-4009-9816"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"He Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079945543","display_name":"Sae Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sae Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070626557","display_name":"Neil Harrison Bander","orcid":"https://orcid.org/0000-0003-4642-0759","observed_orcids":["https://orcid.org/0000-0003-4642-0759"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil H. Bander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051368970","display_name":"Philip W. Howard","orcid":"https://orcid.org/0000-0001-6392-2289","observed_orcids":["https://orcid.org/0000-0001-6392-2289","https://orcid.org/0000-0001-7828-1154"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip W. Howard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055669649","display_name":"John Anthony Hartley","orcid":"https://orcid.org/0000-0003-3737-9897","observed_orcids":["https://orcid.org/0000-0003-3737-9897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John A. Hartley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050730829","display_name":"Steve Coats","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Coats","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019757898","display_name":"David A. Tice","orcid":"https://orcid.org/0000-0001-7819-1351","observed_orcids":["https://orcid.org/0000-0001-7819-1351"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Tice","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101987129","display_name":"Ronald Herbst","orcid":"https://orcid.org/0000-0003-1702-7739","observed_orcids":["https://orcid.org/0000-0003-1702-7739"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald Herbst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006107477","display_name":"Patrick H. van Berkel","orcid":"https://orcid.org/0000-0002-7315-0347","observed_orcids":["https://orcid.org/0000-0002-7315-0347"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick H. van Berkel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.365200012922287,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.365200012922287,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.36010000109672546,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.20389999449253082,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyrrolobenzodiazepine","display_name":"pyrrolobenzodiazepine","score":0.9490000009536743},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9950000047683716},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.8960000276565552},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9190000295639038},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.878000020980835},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.3659999966621399},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.824999988079071},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.645179033279419},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6412541270256042},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5605120062828064},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5208538174629211},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4482021927833557},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.41988301277160645},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41075146198272705},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39857491850852966},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3859463334083557},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37326255440711975},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2110629677772522},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16610947251319885},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14023488759994507},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.1365257203578949},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22505436","doi":"https://doi.org/10.1158/1535-7163.22505436","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22505436","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22505436.v1","doi":"https://doi.org/10.1158/1535-7163.22505436.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22505436.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/39965325","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22505436","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_S1-S7_from_Antitumor_Activity_of_MEDI3726_ADCT-401_a_Pyrrolobenzodiazepine_Antibody_Drug_Conjugate_Targeting_PSMA_in_Preclinical_Models_of_Prostate_Cancer/22505436","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22505436","doi":"https://doi.org/10.1158/1535-7163.22505436","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22505436","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362534720.pdf","grobid_xml":"https://content.openalex.org/works/W4362534720.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362542158","https://openalex.org/W2887583157","https://openalex.org/W3008651065","https://openalex.org/W2890549955","https://openalex.org/W2741002721","https://openalex.org/W3148342899","https://openalex.org/W4361863756","https://openalex.org/W2892351529","https://openalex.org/W2508648545","https://openalex.org/W1989090639"],"abstract_inverted_index":{"Supplementary":[0,19,39,53,64,70,90],"Figure":[1,20,40,54,65,71,91],"S1.":[2],"Retention":[3],"of":[4,24,45,57],"MEDI3726":[5,97],"activity":[6,88],"in":[7,28,48,86],"human,":[8],"cynomolgus":[9],"monkey":[10],"plasma":[11],"or":[12],"PBS":[13],"for":[14],"up":[15],"to":[16],"7":[17],"days.":[18],"S2.":[21],"Kaplan-Meier":[22],"analysis":[23],"the":[25,29,50,58],"Time-to-Endpoint":[26],"Survival":[27],"(A)":[30],"LNCaP,":[31],"(B)":[32],"CWR22Rv1,":[33],"and":[34,60,82],"(C)":[35],"PC-3":[36],"Xenograft":[37,51],"Studies.":[38],"S3.":[41],"In":[42],"Vivo":[43],"Activity":[44],"Isotype":[46],"Control":[47],"CWR22Rv1":[49],"Model.":[52],"S4.":[55],"Cytotoxicity":[56],"Warheads":[59],"Their":[61],"Associated":[62],"ADCs.":[63],"S5.":[66],"gamma-H2AX":[67],"IHC":[68],"Results.":[69],"S6.":[72],"Body":[73],"weight":[74],"measurements":[75],"from":[76],"a":[77,83],"representative":[78],"cell":[79],"line":[80],"xenograft":[81],"LuCaP":[84],"PDX":[85],"vivo":[87],"studies.":[89],"S7.":[92],"Hematology":[93],"Parameters":[94],"(Males)":[95],"following":[96],"Administration":[98],"at":[99],"0":[100],"(control)":[101],"&":[102],"0.6":[103],"mg/kg.":[104]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}